Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Axis-Shield's testosterone test gains FDA approval:

This article was originally published in Clinica

Executive Summary

Anglo-Norwegian firm Axis-Shield has received FDA approval to market its testosterone assay in the US using Abbott Laboratories AxSYM range of laboratory analysers. Axis-Shield will manufacture the test at its Dundee, Scotland facilities, having launched the testosterone test in non-US markets earlier this year. Detecting abnormal levels of testosterone can help diagnose conditions such as infertility, pituitary disease, obesity, adrenal disease and polycystic ovary syndrome. Axis-Shield claims there are already 17,000 AxSYM analysers placed in hospitals and laboratories worldwide, and plans to extend its range of AxSYM-based assays under its agreement with Abbott.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT060130

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel